Advancing Highly Sensitive Point-of-Care Tests for Malaria

As malaria programs move closer to achieving elimination, more sensitive point-of-care diagnostic tests are needed to detect the final parasite reservoirs. PATH and collaborators have developed a highly sensitive diagnostic test for Plasmodium falciparum malaria to use in the surveillance and mass screen-and-treat programs critical for malaria elimination.

Publication date: April 2017

Advancing Highly Sensitive Point-of-Care Tests for Malaria

312.5 KB PDF

Hard copies are not available. 

View Resource